{"name":"Tyme, Inc","slug":"tyme-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNVVhvbFlQN2lZaGxCNmRMSV9GYlRWbmhEMUZVcmxuaHpYeGU2ZDFRcVItMkZ2YVp1cEdrY3ozaWJmVTVTSldBZXkwUExmSWQwVDZNakVoczBSamp6VTZkNk5zNjJ2WHR0UG94ZlZKNDR4b19oQk5Hemx5NjhPdjZaMUU3ZV8tQ3BxeEpLUmMwVHhQQXVMaUZKR1dn?oc=5","date":"2026-02-16","type":"pipeline","source":"The Business Journals","summary":"Jacksonville-founded TyMe Institute nearing June opening for cancer prevention facility in St. Johns County - The Business Journals","headline":"Jacksonville-founded TyMe Institute nearing June opening for cancer prevention facility in St. Johns County","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxOT3V0UTc3SUE5NDZKYmcxR292V2pYcVhMWjlfaGRfZlpqYTlQYzhRd3RoNXI3N3doZU5ReEVoZmI4RUlBYkM2VWJwNnFWc2xwajk0eWp4RWJvWnZVS1NrRlJuOHlVX1BxQmZPWXMwWFRKWjBpU240ajlrUzNpcWpwR05RMUtycGNUMHZmOHRMWEtNS1NxLUxmNXJxWnlPREhkbThuS0RSSU15cWM5ZUJUam0zd3ZhOGJVaTB3TDl2WTlBMHFKNzZ1NDFpaXNUYzM2LWgtcUl4VHNNbm8yWVc1SVZTT1ota2ZJb3RZVGphY0hOR2FsZ1R5MWs4NVk3MEVYd1dWMk8xSEIwRUZJ?oc=5","date":"2025-04-24","type":"pipeline","source":"PR Newswire","summary":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | DelveInsight - PR Newswire","headline":"IBRANCE's Market Growth Marks a Significant Step Forward in Metastatic HR+/HER2− Breast Cancer Treatment Landscape | Del","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwJBVV95cUxNbDVNY2Vtekhac0k0RU5Rc0hGN3FTVFA2UTRaMlRvbnduYW54TEtEUFpmdjIzYWUxQ1k1Rmt4R3JtVEtPTkFQMWRhTmxtOEctdGJMN0RCSlJ2dWxsWWRkN0xucC1ETkxZSnhEX0JEeGZVTXpTMjZSeDJwbWphbGRQa3lNTEFkTG5XOUZDZ1ZSa0JXWFlUbGFhRDZ0M29QSlIxQUg1Rk8wMXlUUEFEWG5CQndyS0tDQVp2T2tmM0lzeTZRSEtIbk1DVzY3ZWVpX0RZcWJ6MWtSS0FJd21JTTNwVXcxeHpBSXJlVHl3MmIxMUtlQWVLaVlfTVhvWUdobkRiVDFTM0pkWTFYSHo4RjN3TU1VYUV5dk1XZjRya3ptcUwwREpUamVveE9QYU4zSUxSU3djOWZNTQ?oc=5","date":"2024-10-01","type":"trial","source":"GlobeNewswire","summary":"Breast Cancer Clinical Trial Pipeline Appears Robust With - GlobeNewswire","headline":"Breast Cancer Clinical Trial Pipeline Appears Robust With","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE4zTVFlU1J2ZWxwaFdqdGtBdjduYkFyRXZudGFhY1AxeTRhc1MyeXBUdXFmMTJmcllrbE9DMXJSa0tqTkEtR2dhellBaXZhYXV5ZXgza2RUZlVoWnFtdjdsX1dibmpxVS1FNk43Rmw5RUpRZzNFSVJJ?oc=5","date":"2022-11-07","type":"pipeline","source":"GuruFocus","summary":"Richard Anthony Cunningham, Net Worth (2026) - GuruFocus","headline":"Richard Anthony Cunningham, Net Worth (2026)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNSHY3U2NUaW9jOWxkeDFhU2hQUDh2MXpDZGNTVDBGdFpHMTVtb244ZDh1MDBWeGl2b21qTGhDX29KbjVDRUxKZ2pvcHpVVGNFZ3REQ2lUQktDbERJeDZGb0pjVXFnTTNfOFpncEUwT1F1bzh1OU1rSmZBRVQtSTBKREU5QkZxUzRjc1VGeFo2SWxSVE02RkE0RzVrQ2JISlgyYUwtUjNNM2MybWhqMlBPOUFmMDY4TXNOQjEzX3RB?oc=5","date":"2022-09-16","type":"deal","source":"Faegre Drinker Biddle & Reath LLP","summary":"Tyme Technologies Completes Merger With Syros Pharmaceuticals - Faegre Drinker Biddle & Reath LLP","headline":"Tyme Technologies Completes Merger With Syros Pharmaceuticals - Faegre Drinker Biddle & Reath LLP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxPOTRrZGZDVmdsY0ozWHhYYTQ0c1JESnprTTljQzFQLXRsbFJsalFKVVdVbjRpMndPeHRpQ0pvdzM4dnNMUGFqMi1xVkVfR2x1eFRXZERIajktcFhHVEltNXlXbUZhWFU3Vk53SEgtMWU5bkdZY1pfbXFYWWZKN0NWVGltTTN6RF9GWWRwSy1UOWdneUh6ZGI5c0d5LW5kZ25Ec0VQQWVLaEpSOERCb3RuXzJsVlhxdl9UYm9sODJuSF80UXNqZEVHSHp5UVhzX3JraVFYLWQxOGtKb1k1enk4?oc=5","date":"2022-09-16","type":"deal","source":"Business Wire","summary":"Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement - Business Wire","headline":"Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxQbU1JMEVFWEwxQTNuZ3hfNFh0cXZ4T1NzTTlZcERtWW42dGNTZlQtR0V2YWpuaENiOHlLNFJ3VkI3VUNyNTV1TW9LQ25WTWRZSDAzMHpxZkhoTzl3ajZsMFpGd0poQUdFZlpFSjNLTEtVUnJaZHVLV29BbWQ4U2JmZXI1MFAyRVNtd1FZ?oc=5","date":"2022-07-05","type":"deal","source":"Yahoo Finance","summary":"TYME Technologies Shares Surge On Merger Agreement With Syros Pharma - Yahoo Finance","headline":"TYME Technologies Shares Surge On Merger Agreement With Syros Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOMHVweXFqNGlCb2tDdThsVzNkMnlfS1liaWNjWW92RGtoTWM4YUZ2bHVFRGdsMW9Cb1NaMXVGWGlDQndkV3dlMnFwWEdWVmlyQkxvSnhHQmNwT1hsWVZkNVZVU1Frb0J4MEs1cUNhdC0tSmwxeFpTNlotbEJ0eFR3eUhQTXVFd0VsNGpORXJrcGJmZTdlYnNHM0g2V0pQR2lyMVdpRFZPY29LdGJGRWUwV21rTzlMa0JrTllqTmZTUQ?oc=5","date":"2022-07-05","type":"deal","source":"Fierce Biotech","summary":"Buying Tyme: Syros inks $190M merger, Flagship-backed financing to extend cash runway into 2025 - Fierce Biotech","headline":"Buying Tyme: Syros inks $190M merger, Flagship-backed financing to extend cash runway into 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQcjNFa1RJRDN3UE1rQXZnUUFXcC1rdUhQSUNJcHA4QVc4SFFrYjJ3WmlDdmxXN3lUSGVVX0ZtUFBsYzRBc2o3R2FOZzVXQVBoY1YxQmUyNGgyOU9XRkZVOEtpVm5iVmJSWEtBVFBzdURUWHMwaVBkRDRJUnU4T0ZEdWNCeXhubHROZnBhMGRGR011RnNYLXVtV2pwWE9mT2dUa2ptMTB1dVZmNGhR?oc=5","date":"2022-07-05","type":"deal","source":"The Pharma Letter","summary":"Syros acquires TYME and announces $130 million private placement - The Pharma Letter","headline":"Syros acquires TYME and announces $130 million private placement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9rQllaLWFtazJra1BTSmFGUXVSaHdKZVdVNzN1cTNERkJPNDBUVF9DVnExS0UyNmVrS2w5WWVtMHVqcDVOQzZ6ZFFxRjFGMnFVY2RmN2ZIMG5SR3hkeEQ1UmhIRFNFQlJKY2c?oc=5","date":"2022-05-02","type":"trial","source":"Wiley Online Library","summary":"A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic cancer treated in the second line and beyond - Wiley Online Library","headline":"A randomized phase II study of SM-88 plus methoxsalen, phenytoin, and sirolimus in patients with metastatic pancreatic c","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxNdkVCZ0MwMm1BTG1RSnl3SktNc3FuT0pCbUowbFphSnZ5YzdwREM5RS02WFpVZU9HZ0Z5UC1KbE9QT2tQdXhkSHlJMFNHaHRFbDFmZGMtQ0c0RnFRdjlLRjdBNDlDdjlBX3FiUFFvTEY5Z2tMeXJsaDZEQkFRRHZacGpkZmtORXZWN00yOXZhaTBRWEthUlJoeG5WWmxDSTFwM2JoR24xYmI4RE10MURxYlFNQkhEX2lobkE?oc=5","date":"2020-08-03","type":"pipeline","source":"New Jersey Business Magazine","summary":"TYME Announces Orphan Drug Designation for Potential Pancreatic Cancer Treatment - New Jersey Business Magazine","headline":"TYME Announces Orphan Drug Designation for Potential Pancreatic Cancer Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxNYzJyQnowLXhvOFJQSk1OUDVIUVdtc3lMT2lnOUNiYlczNjRZYUNDbGdqeEUyT18xV2tUV3Z2X1ktN0t6UzFqZ3ljT0lMeE84YTAyU3hXNEVFd0h3cGdBMGNkcnNNekNXZFlGTFktaG90MnROclZoTGlXQUo5QzhnOVY5bUVMWVd0cW16Ym00ajNPNU9qMnUtZ1RnRkxHdklwenR3UExrVmVlMEphVTVkSTVQRjROcFdjY0dqcTFhSk1OS2NkVmZPOUJ3SE1BRlFnTDBMVnp1NlBwUVpIelJTUzMyWU9KZmdxb3B5Q25jdWJGVmxLSWtYQk5xeDl4WkdzWXp3NlAtNmxRT1h0NGJRcDZNZTFyazFScUk1UmUwY0hIODJaQ2J2d3BvYUt6TkdNblE?oc=5","date":"2020-01-08","type":"deal","source":"Business Wire","summary":"Tyme Technologies and Eagle Pharmaceuticals Announce Strategic Collaboration to Advance Innovative Oral SM-88 for the Treatment of Patients with Cancer - Business Wire","headline":"Tyme Technologies and Eagle Pharmaceuticals Announce Strategic Collaboration to Advance Innovative Oral SM-88 for the Tr","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}